Journal of Clinical Medicine (Apr 2022)

First-Trimester Fetal Hepatic Artery Examination for Adverse Outcome Prediction

  • Bartosz Czuba,
  • Piotr Tousty,
  • Wojciech Cnota,
  • Dariusz Borowski,
  • Agnieszka Jagielska,
  • Mariusz Dubiel,
  • Anna Fuchs,
  • Magda Fraszczyk-Tousty,
  • Sylwia Dzidek,
  • Anna Kajdy,
  • Grzegorz Świercz,
  • Sebastian Kwiatkowski

DOI
https://doi.org/10.3390/jcm11082095
Journal volume & issue
Vol. 11, no. 8
p. 2095

Abstract

Read online

Objective: To assess whether there are differences in first-trimester fetal hepatic artery flows depending on pregnancy outcomes. Methods: The prospective study conducted in 2012–2020 included 1841 fetuses from singleton pregnancies assessed during the routine first-trimester ultrasound examination (between 11- and 14-weeks’ gestation). Also, each fetus was examined to determine their hepatic artery flows by measuring the artery’s pulsatility index (HA-PI) and peak systolic velocity (HA-PSV). Results: The fetuses that were classified as belonging to the adverse pregnancy outcome group (those with karyotype abnormalities and congenital heart defects) were characterized by a significantly lower HA-PI and higher HA-PSV compared to normal outcome fetuses. Conclusion: Hepatic artery flow assessment proved to be a very useful tool in predicting adverse pregnancy outcomes, in particular karyotype abnormalities and congenital heart defects.

Keywords